文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

婴儿配方食品中添加合生菌、益生菌或益生元对足月婴儿的影响:系统评价。

Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review.

机构信息

Division of Human Nutrition, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, Western Cape, South Africa.

出版信息

Nutr J. 2012 Oct 4;11:81. doi: 10.1186/1475-2891-11-81.


DOI:10.1186/1475-2891-11-81
PMID:23035863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3544682/
Abstract

BACKGROUND: Synbiotics, probiotics or prebiotics are being added to infant formula to promote growth and development in infants. Previous reviews (2007 to 2011) on term infants given probiotics or prebiotics focused on prevention of allergic disease and food hypersensitivity. This review focused on growth and clinical outcomes in term infants fed only infant formula containing synbiotics, probiotics or prebiotics. METHODS: Cochrane methodology was followed using randomized controlled trials (RCTs) which compared term infant formula containing probiotics, prebiotics or synbiotics to conventional infant formula with / without placebo among healthy full term infants. The mean difference (MD) and corresponding 95% confidence intervals (CI) were reported for continuous outcomes, risk ratio (RR) and corresponding 95% CI for dichotomous outcomes. Where appropriate, meta-analysis was performed; heterogeneity was explored using subgroup and sensitivity analyses. If studies were too diverse a narrative synthesis was provided. RESULTS: Three synbiotic studies (N = 475), 10 probiotics studies (N = 933) and 12 prebiotics studies (N = 1563) were included. Synbiotics failed to significantly increase growth in boys and girls. Use of synbiotics increased stool frequency, had no impact on stool consistency, colic, spitting up / regurgitation, crying, restlessness or vomiting. Probiotics in formula also failed to have any significant effect on growth, stool frequency or consistency. Probiotics did not lower the incidence of diarrhoea, colic, spitting up / regurgitation, crying, restlessness or vomiting. Prebiotics in formula did increase weight gain but had no impact on length or head circumference gain. Prebiotics increased stool frequency but had no impact on stool consistency, the incidence of colic, spitting up / regurgitation, crying, restlessness or vomiting. There was no impact of prebiotics on the volume of formula tolerated, infections and gastrointestinal microflora. The quality of evidence was compromised by imprecision, inconsistency of results, use of different study preparations and publication bias. AUTHORS' CONCLUSIONS: There is not enough evidence to state that supplementation of term infant formula with synbiotics, probiotics or prebiotics does result in improved growth or clinical outcomes in term infants. There is no data available to establish if synbiotics are superior to probiotics or prebiotics.

摘要

背景:在婴儿配方奶粉中添加合生剂、益生菌或益生元是为了促进婴儿的生长和发育。之前的综述(2007 年至 2011 年)关注的是给予益生菌或益生元的足月婴儿预防过敏疾病和食物过敏。本综述专注于仅用含有合生剂、益生菌或益生元的婴儿配方奶粉喂养的足月婴儿的生长和临床结局。

方法:采用随机对照试验(RCT)的 Cochrane 方法,比较含有益生菌、益生元或合生剂的婴儿配方奶粉与含有安慰剂的常规婴儿配方奶粉在健康足月婴儿中的差异。对于连续性结局,报告了均值差(MD)和相应的 95%置信区间(CI),对于二分类结局,报告了风险比(RR)和相应的 95%CI。在适当的情况下进行了 meta 分析;使用亚组和敏感性分析探索异质性。如果研究差异太大,则提供叙述性综合分析。

结果:纳入了 3 项合生剂研究(N=475)、10 项益生菌研究(N=933)和 12 项益生元研究(N=1563)。合生剂并未显著增加男孩和女孩的生长。使用合生剂增加了粪便频率,但对粪便稠度、绞痛、溢奶/反流、哭闹、不安或呕吐没有影响。配方奶粉中的益生菌也没有对生长、粪便频率或稠度产生任何显著影响。益生菌并不能降低腹泻、绞痛、溢奶/反流、哭闹、不安或呕吐的发生率。配方奶粉中的益生元确实增加了体重增加,但对身长或头围增加没有影响。益生元增加了粪便频率,但对粪便稠度、绞痛、溢奶/反流、哭闹、不安或呕吐的发生率没有影响。益生元对配方奶耐受量、感染和胃肠道微生物群没有影响。证据质量因不精确、结果不一致、使用不同的研究制剂和发表偏倚而受到损害。

作者结论:没有足够的证据表明在婴儿配方奶粉中添加合生剂、益生菌或益生元会导致足月婴儿生长或临床结局的改善。目前尚无数据表明合生剂优于益生菌或益生元。

相似文献

[1]
Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review.

Nutr J. 2012-10-4

[2]
Probiotics in infants for prevention of allergic disease.

Cochrane Database Syst Rev. 2025-6-13

[3]
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.

Cochrane Database Syst Rev. 2023-10-23

[4]
Probiotics, prebiotics infant formula use in preterm or low birth weight infants: a systematic review.

Nutr J. 2012-8-28

[5]
Probiotics for management of functional abdominal pain disorders in children.

Cochrane Database Syst Rev. 2023-2-17

[6]
Effectiveness and safety study of formula containing probiotics, prebiotics, synbiotics on fullterm infants' growth - a systematic review and meta-analysis of randomized controlled study.

Eur J Clin Nutr. 2024-10-24

[7]
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.

Cochrane Database Syst Rev. 2022-9-20

[8]
Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants.

Cochrane Database Syst Rev. 2006-10-18

[9]
Probiotics for treatment of chronic constipation in children.

Cochrane Database Syst Rev. 2022-3-29

[10]
Long chain polyunsaturated fatty acid supplementation in infants born at term.

Cochrane Database Syst Rev. 2017-3-10

引用本文的文献

[1]
Microbiota-A Rescuing Modulator in Children Struggling with Functional Constipation.

Microorganisms. 2025-6-27

[2]
The early-life gut microbiome in common pediatric diseases: roles and therapeutic implications.

Front Nutr. 2025-5-29

[3]
Efficacy of prebiotic, probiotic and synbiotic administration in improving growth in children aged 0-59 months living in low- and middle-income countries: a systematic review and meta-analysis.

BMC Pediatr. 2025-2-27

[4]
Infant formula with added GG supported adequate growth and was well tolerated in healthy term infants: a randomized controlled trial.

Front Pediatr. 2024-10-23

[5]
The effect of probiotic, prebiotic, and synbiotic supplements on anthropometric measures and respiratory infections in malnourished children: a systematic review and meta-analysis of randomized controlled trials.

BMC Pediatr. 2024-11-6

[6]
SLAM 216-Derived Extracellular Vesicles Promote Intestinal Maturation in Mouse Organoid Models.

J Microbiol Biotechnol. 2024-10-28

[7]
Bowel function in a prospective cohort of 1052 healthy term infants up to 4 months of age.

Eur J Pediatr. 2024-8

[8]
Gastrointestinal tolerability of organic infant formula compared to traditional ‎infant formula: A systematic review.

World J Clin Pediatr. 2024-3-9

[9]
The effects of prebiotic, probiotic or synbiotic supplementation on overweight/obesity indicators: an umbrella review of the trials' meta-analyses.

Front Endocrinol (Lausanne). 2024

[10]
Gut Microbiome-Targeted Nutrition Interventions and Growth among Children in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.

Curr Dev Nutr. 2024-2-14

本文引用的文献

[1]
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.

Cochrane Database Syst Rev. 2011-11-9

[2]
Probiotics for preventing acute upper respiratory tract infections.

Cochrane Database Syst Rev. 2011-9-7

[3]
Probiotics for treating acute infectious diarrhoea.

Cochrane Database Syst Rev. 2010-11-10

[4]
Diagnostic value of interleukin-6 and C-reactive protein on early onset bacterial infection in preterm neonates with respiratory distress.

J Perinat Med. 2010-9

[5]
Probiotics.

Am J Health Syst Pharm. 2010-3-15

[6]
Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial.

Clin Exp Allergy. 2010-2-22

[7]
Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy.

J Nutr. 2010-1-20

[8]
Pro- and prebiotic supplementation induces a transient reduction in hemoglobin concentration in infants.

J Pediatr Gastroenterol Nutr. 2009-11

[9]
Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial.

Br J Nutr. 2009-9

[10]
A formula containing galacto- and fructo-oligosaccharides prevents intestinal and extra-intestinal infections: an observational study.

Clin Nutr. 2009-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索